Immunoinhibitory effects of anti-tuberculosis therapy induce the host vulnerability to tuberculosis recurrence
Microbiology Spectrum · 02.07.2024 · 12 (7)
DOI: 10.1128/spectrum.00412-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 02.07.2024. Verfasst von Isha Pahuja und 9 weiteren Autor:innen. Beteiligte Einrichtung: Immunobiology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India. Hauptthemen laut MEDLINE: Antitubercular Agents, Tuberculosis, Mycobacterium tuberculosis, Cytokines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DST | Science and Engineering Research Board (SERB), Department of Science and Technology, Ministry of Science and Technology, India (DST).
Abstract (Originalsprache)
The host immune responses play a pivotal role in the establishment of long-term memory responses, which effectively aids in infection clearance. However, the prevailing anti-tuberculosis therapy, while aiming to combat tuberculosis (TB), also debilitates innate and adaptive immune components of the host. In this study, we explored how the front-line anti-TB drugs impact the host immune cells by modulating multiple signaling pathways and subsequently leading to disease relapse. Administration of these drugs led to a reduction in innate immune activation and also the cytokines required to trigger protective T cell responses. Moreover, these drugs led to activation-induced cell death in the mycobacterial-specific T cell leading to a reduced killing capacity. Furthermore, these drugs stalled the T cell differentiation into memory subsets by modulating the activation of STAT3, STAT4, FOXO1, and NFκB transcription factors and hampering the Th1 and Th17-mediated long-term host protective memory responses. These findings suggest the urgent need to augment directly observed treatment, short-course (DOTS) therapy with immunomodulatory agents to mitigate the adverse effects linked to the treatment. IMPORTANCE As a central component of TB eradication initiatives, directly observed treatment, short-course (DOTS) therapy imparts immune-dampening effects during the course of treatment. This approach undermines the host immune system by delaying the activation process and lowering the immune response. In our investigation, we have unveiled the impact of DOTS on specific immune cell populations. Notably, the signaling pathways involving STAT3 and STAT4 critical for memory responses and NFκβ associated with pro-inflammation were substantially declined due to the therapy. Consequently, these drugs exhibit limited effectiveness in preventing recurrence of the disease. These observations highlight the imperative integration of immunomodulators to manage TB infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunobiology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
- Department of Molecular Medicine, Jamia Hamdard University, New Delhi, India.
- Department of Microbiology, Ram Lal Anand College, University of Delhi, New Delhi, India.
- School of Computer & Systems Sciences, Jawaharlal Nehru University, New Delhi, India.
ORCID-Profile: Isha Pahuja, Ashima Bhaskar, Ved Prakash Dwivedi
Förderung
- DST | Science and Engineering Research Board (SERB)
- Department of Science and Technology, Ministry of Science and Technology, India (DST)
Zitieren
APA
Pahuja, I., Ghoshal, A., Okieh, A. A., Verma, A., Negi, K., Agarwal, M., Chandra, N. S., Sharma, S. K., Bhaskar, A., & Dwivedi, V. P. (2024). Immunoinhibitory effects of anti-tuberculosis therapy induce the host vulnerability to tuberculosis recurrence. Microbiology Spectrum, 12(7). https://doi.org/10.1128/spectrum.00412-24
Vancouver
Pahuja I, Ghoshal A, Okieh AA, Verma A, Negi K, Agarwal M, et al. Immunoinhibitory effects of anti-tuberculosis therapy induce the host vulnerability to tuberculosis recurrence. Microbiology Spectrum. 2024;12(7). doi:10.1128/spectrum.00412-24
BibTeX
@article{Pahuja2024,
author = {Pahuja, Isha and Ghoshal, Antara and Okieh, Ahmed Abdallah and Verma, Akanksha and Negi, Kriti and Agarwal, Meetu and Chandra, Nidhi Subhash and Sharma, Saurabh Kumar and Bhaskar, Ashima and Dwivedi, Ved Prakash},
title = {Immunoinhibitory effects of anti-tuberculosis therapy induce the host vulnerability to tuberculosis recurrence},
journal = {Microbiology Spectrum},
year = {2024},
volume = {12},
number = {7},
doi = {10.1128/spectrum.00412-24}
}
EUVIMED